Advanced bladder cancer: New agents and new approaches. A review-Reference-Cited by-同舟云学术

Advanced bladder cancer: New agents and new approaches. A review

Published:2013-01 Issue:1 Volume:31 Page:9-16
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Volpe Andrea,Racioppi Marco,D'Agostino Daniele,D'Addessi Alessandro,Marangi Francesco,Totaro Angelo,Pinto Francesco,Sacco Emilio,Battaglia Sandra,Chiloiro Giuditta,Bassi Pier Francesco

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference63 articles.

1. Cancer Statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Cancer Incidence in Five Continents,2002

3. Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort;Bassi;J Urol,1999

4. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients;Stein;J Clin Oncol,2001

5. Cystectomy for bladder cancer: A contemporary series;Dalbagni;J Urol,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological NF‐κB inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities.;Molecular Oncology;2023-09-20

2. Gallium and gallium semiconductor compounds;Handbook on the Toxicology of Metals;2022

3. Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer;Molecules;2021-02-26

Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules

;International Journal of Nanomedicine;2019-12

5. Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression;Clinical Genitourinary Cancer;2019-08